Life Sciences Times

Ascidian Therapeutics and Forge Biologics Partner to Advance RNA Editing Therapy for Stargardt Disease

Kelonia Therapeutics Receives FDA Clearance to Advance KLN-1010 In Vivo CAR-T Therapy for Multiple Myeloma

Nocion Therapeutics Expands Series B to $93 Million to Advance Late-Stage Development of Taplucainium for Chronic Cough

VideaHealth Launches AI Leadership Council to Guide Responsible Use of Artificial Intelligence in Dentistry

Prudentia Sciences Raises $20 Million Series A to Advance AI-Driven Due Diligence in Life Sciences Dealmaking

Sarepta Submits Clinical Trial Application for First-in-Human Study of SRP-1005 in Huntington’s Disease

Ventus Therapeutics Names VENT-04 as Development Candidate for Inflammatory Diseases

DEM BioPharma to Present Preclinical Data on DEM301 at 2026 ASCO Gastrointestinal Cancers Symposium

Kincell Bio Promotes Larry Pitcher to Chief Executive Officer to Drive Growth in Cell Therapy Manufacturing

1910 Publishes PEGASUS AI Model for Designing Cell-Permeable Macrocyclic Peptides